Expression of Certain Leukemia/Lymphoma Related microRNAs and its Correlation with Prognosis in Childhood Acute Lymphoblastic Leukemia

Karolina Nemes, Monika Csóka, Noémi Nagy, +6

Pathology & Oncology Research

Hematological MalignancyTumor BiologyMedicineMixed-phenotype Acute LeukemiaMalignant Blood Disorder +7

Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease – a combined tissue microarray, in vitro and in vivo study

Ágnes Márk, Melinda Hajdú, Zsófia Váradi, +8

BMC Cancer

Expression of mTORC1/2-related proteins in primary and brain metastatic lung adenocarcinoma

Ildikó Krencz, Anna Sebestyén, Katalin Fábián, +5

Human Pathology

MedicinePathologyMtorc1/2-related ProteinsBronchial NeoplasmCancer Biology +3

The Activated Targets of mTOR Signaling Pathway Are Characteristic for PDGFRA Mutant and Wild-type Rather Than KIT Mutant GISTs

Zoltàn Sápi, Tibor Füle, Melinda Hajdu, +5

Diagnostic Molecular Pathology

EngineeringPathologyPdgfra MutantPathway Are CharacteristicMtor Pathway +21

Mammalian Target of Rapamycin (mTOR) Activity Dependent Phospho-Protein Expression in Childhood Acute Lymphoblastic Leukemia (ALL)

Karolina Nemes, Anna Sebestyén, Ágnes Márk, +9

PLoS ONE

Mixed-phenotype Acute LeukemiaImmunologyIncreased Mtor ActivityTumor BiologyMyeloid Neoplasia +14

Rapamycin Plus Doxycycline Combination Affects Growth Arrest and Selective Autophagy-Dependent Cell Death in Breast Cancer Cells

Titanilla Dankó, Gábor Petővári, Dániel Sztankovics, +9

International Journal of Molecular Sciences

Activity and complexes of mTOR in diffuse large B-cell lymphomas—a tissue microarray study

Anna Sebestyén, T. Sticz, Ágnes Márk, +6

Modern Pathology

Hematological MalignancyTumor BiologyLymphoid NeoplasiaImmunologyCancer Cell Biology +4

Revisiting CB1 Receptor as Drug Target in Human Melanoma

István Kenessey, Balázs Bánki, Ágnes Márk, +4

Pathology & Oncology Research

MelanomaCb1 ReceptorImmune Checkpoint InhibitorMedicineCell Biology +3

mTOR activity and its prognostic significance in human colorectal carcinoma depending on C1 and C2 complex-related protein expression

T. Sticz, Anna Molnár, Ágnes Márk, +6

Journal of Clinical Pathology

mTOR Pathway As a Potential Target In a Subset of Human Medulloblastoma

Tímea Pócza, Anna Sebestyén, Eszter Turányi, +5

Pathology & Oncology Research

Neuro-oncologyHuman MedulloblastomaMedicinePathologyPotential Target +4